GlaxoSmithKline

Investment

What defines a quality stock?

Investment trusts

clock 07 October 2014 •

Economics

RBS chair Hampton to exit for Glaxo role

RBS chairman Sir Philip Hampton is to leave the bank in order to take up an identical position at GlaxoSmithKline, according to reports.

clock 24 September 2014 •

UK

'Taking half of a fund's income away in fees makes no sense to me'

PROFILE

clock 22 July 2014 • 7 min read

Investment

Woodford takes overseas exposure to the max and lifts lid on fund holdings

Neil Woodford is running his largest allocation to overseas stocks since 2013 as he begins management of his new UK equity income fund.

clock 14 July 2014 • 2 min read

Investment

Pharmas' 'hidden value' hailed as mega deals point to re-rating

Growth-focused UK equity managers have joined their income peers in backing pharmaceuticals as deals both real and rumoured send shares rocketing.

clock 28 April 2014 • 3 min read

Economics

Pharma shares rocket on mega M&A deals

GlaxoSmithKline, the UK's largest pharmaceutical group, and rival AstraZeneca, saw shares jump sharply - with the latter up 10% - as a series of deals in the sector boosted prices.

clock 22 April 2014 •

Investment

The UK stocks Lang is shorting to dodge EM woes

Ardevora founder Jeremy Lang has been shorting "in denial" UK companies reliant on emerging markets, while attempting to exploit the domestic recovery.

clock 17 April 2014 • 2 min read

Investment

Matthews on life after Buxton: I am not panicking about flows

THE BIG INTERVIEW

clock 18 February 2014 • 7 min read

Investment

The key sectors powering ahead

SPEACIAL SITs

clock 03 February 2014 • 4 min read

Economics

Nine key stocks for income hunters to follow in 2014

Vodafone, BP and some less predictable names including a number of UK housebuilders have been tipped to lead the income tables in 2014.

clock 06 January 2014 • 1 min read
Trustpilot